.Novo Nordisk is continuing its own press right into hereditary medications, agreeing to compensate ...
.Innovent Biologics has made the instance that its checkpoint inhibitor-cytokine fusion protein has ...
.A period 3 trial of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC)...
.5 months after Rakovina Therapies rotated toward expert system, the cancer-focused biotech has sign...
.Ascendis Pharma has become a possible threat to BioMarin's Voxzogo, mentioning phase 3 development ...
.Though Alkeus Pharmaceuticals' oral eye health condition resource stopped working to significantly ...
.Along with a triad of biotechs attacking the Nasdaq on Friday, it was simple to skip a smaller-scal...
.Immune system gate inhibitors are the superheroes of cancer cells therapy. Medicines like Bristol M...
.Invite to this week's Chutes & Ladders, our summary of significant leadership hirings, shootings...
.Regeneron is back with lasting follow-up for its own LAG-3 prevention as well as PD-1 prevention co...